Stay updated on ADHD care by reviewing new treatment options and navigating the dangers of medication shortages. With patients at risk from counterfeit drugs and overdose as a result of current shortages, now is the time to arm yourself with the knowledge to advocate for and protect your patients. Don't wait—this course is essential for ensuring the safe, effective management of your patients with ADHD.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Jena Quinn, PharmD
CEO
Perfecting Peds

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize the impact of ADHD medication shortages on patient safety, including the risks associated with counterfeit medications.
2. Discuss emerging ADHD treatment options and their potential applications in clinical practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-269-H01-P
Initial release date: 10/7/2024
Expiration date: 10/7/2025
Additional CPE details can be found here.

In today’s landscape of direct-to-consumer advertising, pharmacists are a vital source of guidance for both healthcare providers and patients seeking information on newly FDA-approved medications. Staying up-to-date on the latest drug approvals is crucial for pharmacists to ensure accurate dispensing and to offer thorough education to patients and other providers. This episode highlights several medications approved by the FDA in the last 12 to 18 months, providing essential insights into their clinical use.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Joe Strain, PharmD
Professor Pharmacy Practice
South Dakota State University

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. List unique pharmacological properties for each medication recently approved by the FDA.
2. Recall common side effects, contraindications, known drug interactions, and/or warnings associated with each new medication.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-267-H01-P
Initial release date: 9/30/2024
Expiration date: 9/30/2025
Additional CPE details can be found here.

Join us for a must-listen episode as we explore performance-based payer programs! Uncover the transformative trends of 2024 and get an exclusive preview of what's on the horizon for 2025. We’re moving beyond traditional metrics like prescription fill counts to a new focus on operational, financial, and clinical excellence.

This episode is packed with expert insights and actionable advice to help your pharmacy thrive. Don’t miss out on this opportunity to stay ahead of the curve and help ensure your pharmacy's success. Tune in now!

Host
Suzanne Feeney, PharmD
VP, Pharmacy Retail Operations
McKesson, Health Mart

Guests
Steven Oh, RPh
Director, Managed Care Pharmacy Opportunities
McKesson, Health Mart

Jasmyn Funes, CPhT
Technician, Admin and Marketing Specialist
Cleveland Pharmacy

References
Learn more about CMS' Final Rules impacting Comprehensive Medication Reviews for 2025 here: https://www.federalregister.gov/public-inspection/2024-07105/medicare-program-medicare-advantage-and-the-medicare-prescription-drug-benefit-program-for-contract


The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.